Page last updated: 2024-11-04

hydroxyacetylaminofluorene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hydroxyacetylaminofluorene: A N-hydroxylated derivative of 2-ACETYLAMINOFLUORENE that has demonstrated carcinogenic action. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5896
CHEMBL ID284464
CHEBI ID17931
SCHEMBL ID637635
MeSH IDM0010746

Synonyms (53)

Synonym
hydroxyacetylaminofluorene
n-hydroxy-n-acetyl-2-aminofluorene
n-(9h-fluoren-2-yl)-n-hydroxyacetamide
CHEBI:17931 ,
n-hydroxy-n-2-fluorenylacetamide
wln: l b656 hhj enqv1
n-hydroxy-n-(2-fluorenyl)acetamide
nsc-46522
acetamide, n-hydroxy-n-(2-fluorenyl)-
2-(n-acetylhydroxylamino)fluorene
n-hydroxy-aaf
n-2-fluorenyl-n-hydroxyacetamide
nsc46522
2-(n-hydroxyacetamido)fluorene
n-fluoren-2-ylacetohydroxamic acid
n-2-fluorenylacetohydroxamic acid
acetohydroxamic acid, n-fluoren-2-yl-
fluorenyl-2-acethydroxamic acid
n-hydroxy-2-acetaminofluorene
nohfaa
n-hydroxy-2-(acetylamino)fluorene
n-hydroxy-2-faa
n-hydroxy-2-acetylaminofluorene
n-9h-fluoren-2-yl-n-hydroxyacetamide
53-95-2
acetamide, n-9h-fluoren-2-yl-n-hydroxy-
inchi=1/c15h13no2/c1-10(17)16(18)13-6-7-15-12(9-13)8-11-4-2-3-5-14(11)15/h2-7,9,18h,8h2,1h
n-hydroxy acetylaminofluorene
n-acetyl-n-2-fluorenylhydroxylamine
ai3-50466
2-n-hydroxy-acetylaminofluorene
brn 2654276
nsc 46522
ccris 338
2-hydroxyacetylaminofluorene
C03954
n-hydroxy-2-acetamidofluorene ,
CHEMBL284464
6agd02huqc ,
unii-6agd02huqc
SCHEMBL637635
n-2-fluorenylacetohydroxamicacid
hydroxy-2-acetylaminofluorene, n-
acetamide, n-fluoren-2-yl-n-hydroxy-
SOKUIEGXJHVFDV-UHFFFAOYSA-N
n-(9h-fluoren-2-yl)-n-hydroxyacetamide #
DTXSID2020719
mfcd00869474
n-(9h-fluoren-2-yl)-n-hydroxy-acetamide
Q5955515
n-9h-fluoren-2-yl-n-hydroxy-acetamide
STARBLD0036706
AKOS040767612

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Neither N-arylhydroxamic acid was toxic to the lymphoblasts, nor mutagenic at the thymidine kinase (tk) locus, in the absence of AHAT over the concentration range examined."( Comparative toxicity and mutagenicity of N-hydroxy-2-acetylaminofluorene and 7-acetyl-N-hydroxy-2-acetylaminofluorene in human lymphoblasts.
Babson, JR; Boteju, LW; Gavitt, NE; Hanna, PE, 1992
)
0.28
"Isolated perfused livers from male Wistar rats were used to study acute and chronic toxic effects of carcinogenic aromatic amines."( Acute and chronic toxicity of aromatic amines studied in the isolated perfused rat liver.
Ambs, S; Neumann, HG, 1996
)
0.29
" Thus, glucuronidation may contribute to the elimination of CYP-mediated reactive intermediate metabolites, preventing a toxic event."( The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines.
Famourzadeh, M; Guengerich, FP; Nguyen, N; Oda, Y; Strassburg, CP; Tukey, RH; Yueh, MF, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" However, a gene dose-response relationship was observed in the same animals for cytosolic acetyl coenzyme A-dependent 2-aminofluorene N-acetyltransferase activity."( The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
Ferguson, RJ; Hein, DW; Kirlin, WG; Ogolla, F; Thompson, LK; Trinidad, A,
)
0.13
" N-OH-AAF dependent ODC induction displayed an almost linear dose-response in the dose range up to 94."( Induction of ornithine decarboxylase and augmentation of tyrosine aminotransferase activity by N-hydroxy-2-acetylaminofluorene and 2-acetylaminofluorene in rat liver. Influence of sex, retinylacetate, indomethacin, and pentachlorophenol.
Bakker, O; Bisschop, A; Meerman, JH; Stavenuiter, JF; van der Heijden, CA; van Wijk, R, 1984
)
0.27
" Four hours after dosing the animals were sacrificed and hepatic DNA was isolated."( Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol.
Beland, FA; Meerman, JH; Mulder, GJ, 1981
)
0.26
"We investigated the role of dosing regimen on ras mutations in chemically induced CD-1 mouse liver tumors."( Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors.
Hammermeister, CL; Joslyn, DJ; Kraynak, AR; Leander, KR; Ledwith, BJ; Manam, S; Nichols, WW; Prahalada, S; Shinder, GA; van Zwieten, MJ, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
2-acetamidofluorenesAn ortho-fused polycyclic arene, or derivative thereof, that consists of 9H-fluorene bearing an acetamido substituent at position 2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase II - Conjugation of compounds73122
Cytosolic sulfonation of small molecules1747

Bioassays (25)

Assay IDTitleYearJournalArticle
AID143757Inhibition of AHAT-catalyzed transacylation of 4-aminoazobenzene1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
N-arylhydroxamic acid N,O-acyltransferase. Positional requirements for the substrate hydroxyl group.
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID22925Rate of methylthio adduct formation catalyzed by partially purified hamster hepatic enzyme per mg protein per 10 min1985Journal of medicinal chemistry, Oct, Volume: 28, Issue:10
Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase.
AID231104Ratio of apparent inactivation rate constant to apparent dissociation (binding) rate constant was determined1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID168252Compound was tested for carcinogenic activity on other sites after various routes administration of the compound; + denotes carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID17851Apparent inactivation rate constant was evaluated1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID17267Apparent dissociation (binding) rate constant was evaluated1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID31275AHAT catalyzed transacylation was determined; Rate expressed as nanomoles of AAB acylated per mg of protein per 5 min1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Arylhydroxamic acid bioactivation via acyl group transfer. Structural requirements for transacylating and electrophile-generating activity of N-(2-fluorenyl)hydroxamic acids and related compounds.
AID86006Percent protection from inactivation of AHAT was determined using L-methionine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID678816TP_TRANSPORTER: Northern blot in vivo Fischer male rat1988Journal of the National Cancer Institute, Nov-02, Volume: 80, Issue:17
Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics.
AID22908Activity measured as 4-aminoazobenzene (AAB) transacetylation rate with partially purified hamster hepatic enzyme1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID168081Compound was tested for carcinogenic activity on ear duct after various routes administration of the compound; + denotes carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID167946Compound was tested for carcinogenic activity on breast after various routes administration of the compound; + denotes carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID168094Compound was tested for carcinogenic activity on liver after various routes administration of the compound; + denotes carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID31274Methylthio adduct formation rate expressed as nanomoles of methylthio adduct formed per mg of protein per 30 min1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Arylhydroxamic acid bioactivation via acyl group transfer. Structural requirements for transacylating and electrophile-generating activity of N-(2-fluorenyl)hydroxamic acids and related compounds.
AID86008Percent protection from inactivation of AHAT was determined using guanosine phosphate1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID24176Observed log rate of methylthio adduct formation1985Journal of medicinal chemistry, Oct, Volume: 28, Issue:10
Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase.
AID86009Percent protection from inactivation of AHAT was determined using t-RNA1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID86007Percent protection from inactivation of AHAT was determined using glutathione1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID86005Percent protection from inactivation of AHAT was determined using L-cysteine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
AID167935Compound was tested for carcinogenic activity on all sites after various routes administration of the compound; + denotes carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID168105Compound was tested for carcinogenic activity on mixed data after various routes administration of the compound; + denotes carcinogenic activity1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (246)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990191 (77.64)18.7374
1990's42 (17.07)18.2507
2000's12 (4.88)29.6817
2010's0 (0.00)24.3611
2020's1 (0.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.44 (24.57)
Research Supply Index5.55 (2.92)
Research Growth Index3.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (1.95%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other251 (98.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]